Related Experiment Videos
Insulin and hypertensive cardiovascular disease
T A Kotchen1, J M Kotchen, I M O'Shaughnessy
1Department of Medicine, Medical College of Wisconsin, Milwaukee 53226, USA.
Current Opinion in Cardiology
|September 1, 1996
Summary
Insulin resistance is linked to cardiovascular disease risks like high blood pressure and abnormal cholesterol, appearing even in youth. Addressing these combined risks is crucial for prevention and treatment strategies.
Area of Science:
- Metabolic Syndrome
- Cardiovascular Disease Risk Factors
Background:
- Insulin resistance is associated with hypertension, dyslipidemia, and hypercoagulability, increasing cardiovascular disease (CVD) risk.
- These metabolic and hemostatic abnormalities can manifest early in life and have a heritable component.
Purpose of the Study:
- To emphasize the need for comprehensive strategies addressing overall CVD risk in patients with insulin resistance.
- To highlight the necessity of further clinical trials in hypertensive or diabetic patients to identify effective interventions for reducing CVD endpoints.
Main Methods:
- This abstract does not detail specific methods but discusses the association between insulin resistance and CVD risk factors.
- It reviews the clinical implications of recognizing this constellation of risk factors.
Main Results:
- Insulin resistance is linked to multiple CVD risk factors, including hypertension, dyslipidemia, and thrombosis.
- These risk factors can be present from a young age and are partly heritable.
Conclusions:
- Preventive and therapeutic approaches for insulin resistance should target overall CVD risk.
- Further research, including clinical trials in patients with hypertension or diabetes, is needed to optimize interventions for reducing definitive CVD outcomes.